Minnesota HF3444 prohibits prior authorization and step therapy for drugs used in opioid use disorder treatment under medical assistance.

Minnesota HF3444 amends the state's medical assistance program to prohibit the use of prior authorization and step therapy for drugs approved by the FDA for treating opioid use disorder. The bill ensures that patients with opioid use disorder can access necessary medications without these barriers. It also mandates that the commissioner provide information to the Formulary Committee on the impact of placing a drug on prior authorization and requires the committee to review and recommend drugs for prior authorization.

Minnesota HF3444 prohibits prior authorization and step therapy for drugs used in opioid use disorder treatment under medical assistance.

Minnesota HF3444 amends the state's medical assistance program to prohibit the use of prior authorization and step therapy for drugs approved by the FDA for treating opioid use disorder. The bill ensures that patients with opioid use disorder can access necessary medications without these barriers. It also mandates that the commissioner provide information to the Formulary Committee on the impact of placing a drug on prior authorization and requires the committee to review and recommend drugs for prior authorization.